![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP... Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Show more
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering of 26,246,720 shares of its...
Statistically Significant Improvement in Percent Predicted Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO) Versus Placebo at Week 24 (Primary Endpoint) and Week 48 (Secondary...
Conference Call to Take Place Tomorrow, Wednesday, June 26, 2024, at 8:00am ET Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the...
Savaraβs Partner, Trillium Health LLC, Presented Data on the Laboratory Blood Test for Diagnosing aPAP Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.285 | 6.25 | 4.56 | 5.11 | 4.49 | 1260809 | 4.92879753 | CS |
4 | 0.995 | 25.8441558442 | 3.85 | 5.11 | 3.375 | 3322256 | 4.08022827 | CS |
12 | 0.165 | 3.52564102564 | 4.68 | 5.31 | 3.375 | 1665046 | 4.20958963 | CS |
26 | 0.565 | 13.2009345794 | 4.28 | 5.7 | 3.375 | 1221738 | 4.50077962 | CS |
52 | 1.725 | 55.2884615385 | 3.12 | 5.7 | 3.07 | 919568 | 4.30640162 | CS |
156 | 3.515 | 264.285714286 | 1.33 | 5.7 | 1.02 | 479220 | 3.40902522 | CS |
260 | 2.225 | 84.9236641221 | 2.62 | 6.48 | 0.69 | 731636 | 2.76583199 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions